Cargando…
Inhibition of Interleukin 10 Signaling after Fc Receptor Ligation and during Rheumatoid Arthritis
Interleukin-10 (IL-10) is a potent deactivator of myeloid cells that limits the intensity and duration of immune and inflammatory responses. The activity of IL-10 can be suppressed during inflammation, infection, or after allogeneic tissue transplantation. We investigated whether inflammatory factor...
Autores principales: | Ji, Jong-Dae, Tassiulas, Ioannis, Park-Min, Kyung-Hyun, Aydin, Ani, Mecklenbräuker, Ingrid, Tarakhovsky, Alexander, Pricop, Luminita, Salmon, Jane E., Ivashkiv, Lionel B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193912/ https://www.ncbi.nlm.nih.gov/pubmed/12782719 http://dx.doi.org/10.1084/jem.20021820 |
Ejemplares similares
-
BAFF controls B cell metabolic fitness through a PKCβ- and Akt-dependent mechanism
por: Patke, Alina, et al.
Publicado: (2006) -
Protein Kinase C β Controls Nuclear Factor κB Activation in B Cells Through Selective Regulation of the IκB Kinase α
por: Saijo, Kaoru, et al.
Publicado: (2002) -
Targeting cytokines in inflammatory diseases: focus on interleukin-1-mediated autoinflammation
por: Kalliolias, George D, et al.
Publicado: (2009) -
Interleukin 6 and Rheumatoid Arthritis
por: Yoshida, Yuji, et al.
Publicado: (2014) -
Interleukin-6 in Rheumatoid Arthritis
por: Pandolfi, Franco, et al.
Publicado: (2020)